Storm rages over cancer drugs that cost an arm and a leg
15 Apr 2019
The fair was jointly hosted by WHO and the government.
Cancer Alliance director, Salome Meyer, said pharmaceutical companies often explain the high cost of newer drugs as due to extensive “research costs”. These costs include the many hundreds of drugs that don’t come to market, as initial trials and work in the laboratory may show them to be ineffective or unsafe. Meyer said much initial drug research at universities around the world is paid for by taxpayers – hence pharmaceutical companies should explain what they pay for their part of the research.
[BACK TO NEWS]